Search
Close this search box.

January 30, 2026

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis Leave a reply Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant

Read more

Copyright © 2023, Qatar Online News. All Rights Reserved